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SMethod: Ninety-nine patient having multi-detected computerized tomography
(MDCT) between December 2011 and December 2012 were included in study. All
patients were selected from individuals who underwent MDCT in our hospital with
a suspicion of coronary artery disease. The levels of the CCS, CIMT and PAPP of the
patients were calculated. Demographic properties, whether or not having risk factors
of atherosclerosis and the laboratory parameters of the study patients have been
recorded.
Results: 25 women (%25,3), 74 men (%74,7) were admitted to our study. The mean
age was 52,813,1. In forty-three patients (%43,4), atherosclerotic plague were
detected in carotid artery. The presence of carotid artery plague (CAP) were associated
the existence of coronary artery disease (CAD) (p<0,001). The occurrence of CAP
were more frequent in patients with diabetes mellitus and hypertension compared
without them (consequently p<0,001; p¼0,003). PAPP-A, CCS and CIMT values
were also higher in patients with diabetes and hypertension. A signiﬁcant correlation
between PAPP-A and CCS (p<0,001), moderate correlation between CCS and CIMT
were observed (p<0,001). Grading the CAD of patients according to MDCT, the
optimal cut-off point of PAPP-A in detecting CAD was 2,35 ng/ml with 94,3%
sensitivity and 68,3% speciﬁcity the optimal cut-off point of right and left CIMT in
detecting CAD was 0,6 mm with 75% sensitivity and 87,3% speciﬁcity for right
CIMT and with 75% sensitivity and 79,4% speciﬁcity for left CIMT.
Conclusion: Our study showed that levels of CIMT, CCS, PAPP-A were associated in
patient with subclinical and obvious CAD. The values of PAPP-A, CCS, and CIMT
have been found higher in patients who has traditional atherosclerotic risk factors.
Accordingly, we concluded that it is proper to use the parameters of PAPP-A, CCS
and CIMT in investigating the subclinical atherosclerosis and in guiding treatment.
However in order to have more precise cut-off points, larger studies must be carried on.C12 JACC VOP-030
Relationship between Coronary Stent Restenosis and Plasma Urotensin II Level
Fethi Yavuz1, Orhan Özer1, Süleyman Ercan1, Murat Yüce1, Hamdi Püs¸üroglu2,
Mustafa Ürkmez3, Vedat Davutoglu1, Hayri Alıcı1, Mehmet Kaplan1,
Fuat Bas¸analan1, Mehmet Tarakçıoglu3
1Department of Cardiology, University of Gaziantep, Gaziantep, 2Department of
Cardiology, University of Bezmialem, Istanbul, 3Department of Biochemistry,
University of Gaziantep, Gaziantep
Aim: Restenosis is an important limitation for coronary stenting. The cause of stent
restenosis is neointimal hyperplasia developed from smooth muscle and matrix. We
aimed to investigate the association between urotensin II (U-II) and restenosis after
coronary stenting which causes endothelial and muscle proliferation and accumulation
of collagen.
Methods: Total 153 patient was enrolled to the study who meet criteria for angio-
graphic indication underwent coronary artery angiography. All patient have history
undergone for coronary stent implantation 3 to 9 months ago. Restenosis is identiﬁed
as more than %50 narrowing inside the stent. Restenosis was observed in 73 and
remaining of 80 patients revealed no critical lesion in stent on angiographic evalua-
tion. Plasma level measurement of U-II was performed in all subjects.
Results: There was statistically signiﬁcant association between restenosis and U-II
level (p¼0.03). High level of U-II level independently was linked with coronary stent
restenosis. In subgroup analysis we also observed following multivariate statistical
signiﬁcance: negative correlation was found between restenosis and renin-angiotensin-
system (RAS) blocker usage (p¼0.040) and right coronary artery (RCA) lesions
interventions (p¼0.018).
Conclusion: This study revealed for the ﬁrst time that there is a signiﬁcant rela-
tionship between coronary stent restenosis and plasma U-II values. According to the
our study ﬁndings high plasma U-II level might be accepted as a risk factors for stent
restenosis. Restenosis is less developed after RCA interventions and taking drug of
RAS blockages. Our study ﬁndings need to be conﬁrmed in further studies.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
